Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Effects of Bioactive Compounds (ARMOLIPID PLUS ®) on Lipid Profile and Clinical Criteria of Metabolic Syndrome in Patients With Serum Elevated LDL-C

NCT01562080 is registered in ClinicalTrials.gov with Rottapharm Spain as lead sponsor.

NCT NCT01562080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01562080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Effects of Bioactive Compounds (ARMOLIPID PLUS ®) on Lipid Profile and Clinical Criteria of Metabolic Syndrome in Patients With Serum Elevated LDL-C
Lead sponsor
Rottapharm Spain
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2012
Completion date
October 31, 2012
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated triglycerides, hyperlipidemia, low-density-lipoprotein-type